《伏立康唑个体化用药指南》解读
|
摘要
《伏立康唑个体化用药指南》是一部由北京大学第三医院药剂科发起,中国药理学会治疗药物监测研究专业委员会批准制定,由兰州大学推荐分级评估、制定与评价(grading of recommendations assessment, development and evaluation, GRADE)中国中心提供方法学支持的临床实践指南。该指南于2017年8月被美国国立指南库(National Guideline Clearinghouse, NGC)正式收录,并于2018年12月发表于《Therapeutic Drug Monitoring》杂志。本文为该指南的中文解读版本,涵盖本部指南所有推荐意见、证据及解读,旨在为临床使用伏立康唑提供参考。
The practice Guideline for Individualized Medication of Voriconazole was launched by Department of Pharmacy,Peking University Third Hospital, approved by Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society, and methodologically supported by Chinese Grading of Recommendations Assessment, Development and Evaluation( GRADE) Center. The guideline was accepted and included by National Guideline Clearinghouse(NGC) on August 2017, and was published on Therapeutic Drug Monitoring on December 2018. This paper is an executive summary version of the guideline including all recommendations, evidence and rationale of the guideline, which aims at providing reference for clinical use of voriconazole.
The practice Guideline for Individualized Medication of Voriconazole was launched by Department of Pharmacy,Peking University Third Hospital, approved by Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society, and methodologically supported by Chinese Grading of Recommendations Assessment, Development and Evaluation( GRADE) Center. The guideline was accepted and included by National Guideline Clearinghouse(NGC) on August 2017, and was published on Therapeutic Drug Monitoring on December 2018. This paper is an executive summary version of the guideline including all recommendations, evidence and rationale of the guideline, which aims at providing reference for clinical use of voriconazole.
引文
[1] Chen K, Zhang X, Ke X, et al. Individalized medication of voriconazole:a practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society[J]. Ther Drug Monit,2018,40(6):663-674.